QA: Allarity Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860657_2026_Allarity_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001860657, Allarity Therapeutics Inc

  xvar xval
0 AssetsCurrent 17,928,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 330,000
3 remainder_Assets 0
4 LiabilitiesCurrent 8,430,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,324,000
9 ResearchAndDevelopmentExpense 6,601,000
10 remainder_Expenses 0
11 remainder_Revenues 320,000
12 remainder_NetIncome 1,374,000
13 remainder_ComprehensiveNetIncome -667,000
  yvar yval
0 Assets 18,258,000
1 Liabilities 8,430,000
2 Expenses 12,925,000
3 Revenues 320,000
4 StockholdersEquity 9,828,000
5 NetIncome -11,231,000
6 ComprehensiveNetIncome -11,564,500
7 BaseVar 20,987,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.739
9 EconomicCapitalRatio 2.09

Edgar->Model Mapping

Feature Distribution

Change over Time